breast implants

August 1, 2019

Allergan Issues Worldwide Recall of Some Breast Implant Products Due to Lymphoma Risk

News

Allergan has issued a worldwide recall of its BIOCELL textured breast implant products, due to the potential risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). The recall — for Allergan’s proprietary ... Read more

May 21, 2019

FDA Won’t Ban Sales of Breast Implants Linked to Lymphoma, But Considers Black Box Warning

News

In announcing that breast implants linked to anaplastic large-cell lymphoma (ALCL) can continue to be sold in the United States, the U.S. Food and Drug Administration (FDA) proposed assurances that the ... Read more

February 14, 2019

FDA Update Shows 457 Cases of ALCL Linked to Breast Implants

News

The number of reported cases of anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) has risen to 457, according to a 2018 update from the U.S. Food and Drug Administration ... Read more

January 10, 2018January 10, 2018

Breast Implants Associated with Small Increased Risk of Anaplastic Large-cell Lymphoma

News

A study found that one in 6,920 women with breast implants will develop anaplastic large-cell lymphoma (ALCL) in the breast before they reach the age of 75. Even though the ... Read more

March 23, 2017March 23, 2017

Breast Implants Linked to Rare Lymphoma Type, According to FDA

News

Anaplastic large cell lymphoma can, in rare cases, develop in women with breast implants, according to a statement by the U.S. Food and Drug Administration (FDA). Lymphoma seems to develop ... Read more

December 4, 2015December 4, 2015

Breast Implant-linked Lymphomas Best Treated by Surgical Removal, Study Finds

News

According to the results of an international study led by researchers at The University of Texas MD Anderson Cancer Center, the optimal treatment for most women with breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) ... Read more